Cargando…
Bacteremia by colistin-resistant Acinetobacter baumannii isolate: a case report
BACKGROUND: Carbapenem-resistant Acinetobacter baumannii infections are a major public health problem worldwide, requiring the use of “old” antibiotics such as polymyxin B and E (colistin). However, there is concern regarding the emergence of isolates resistant to these antibiotics. CASE PRESENTATIO...
Autores principales: | Garcia Casallas, Julio Cesar, Robayo-Amortegui, H., Corredor-Rozo, Z., Carrasco-Márquez, A. M., Escobar-Perez, Javier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505100/ https://www.ncbi.nlm.nih.gov/pubmed/31064407 http://dx.doi.org/10.1186/s13256-019-2062-3 |
Ejemplares similares
-
Survival of carbapenem-resistant Acinetobacter baumannii bacteremia: colistin monotherapy versus colistin plus meropenem
por: Park, So Yeon, et al.
Publicado: (2019) -
Colistin Dependency among Colistin-Heteroresistant Acinetobacter baumannii Isolates
por: Kon, Hadas, et al.
Publicado: (2021) -
Colistin-Resistant Acinetobacter Baumannii Bacteremia: A Serious Threat for Critically Ill Patients
por: Papathanakos, Georgios, et al.
Publicado: (2020) -
1824. Combination therapy of daptomycin/colistin for extreme drug resistant Acinetobacter baumannii bacteremia
por: Lampada, Charis, et al.
Publicado: (2022) -
Transition of colistin dependence into colistin resistance in Acinetobacter baumannii
por: Lee, Ji-Young, et al.
Publicado: (2017)